RARA CRAFT DATABASE for FDA Medical Devices
510(k)K173717

FDA DEVICE FACTS

Integra TITAN Reverse Shoulder System

Integra LifeSciences Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 21, 2018PRODUCT CODEPHX

Indications for use

The TITAN Reverse Shoulder System is indicated for use in a gro ssly deficient rotator cuff join t with severe arthropathy or a previous failed joint replacement with a grossly deficient rotator cuff joint. The patien t’s joint must be anatomically and structurally suited to receiv e the selected implants and a functional de ltoid muscle is necessary to use the device. The Titan Reverse Shoulder System is indicat ed for primary, fractures including proxi mal humeral, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency. The glenoid base plate is intended for cementless application with the addition of screws for fixation. Th e humeral stem is indicated for cemented or uncemented use and the humeral body co mponent is intended for cementless use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 27, 2026